Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy
Authors
Keywords
-
Journal
DIABETES CARE
Volume 46, Issue 4, Pages 742-750
Publisher
American Diabetes Association
Online
2023-02-15
DOI
10.2337/dc22-1915
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GLP ‐1 Receptor Agonists as Adjunctive Treatment for Type 1 Diabetes: Renewed Opportunities through Tailored Approaches?
- (2022) Alessandra Kobayati et al. DIABETES OBESITY & METABOLISM
- Technology in the management of type 2 diabetes – present status and future prospects
- (2021) Aideen Daly et al. DIABETES OBESITY & METABOLISM
- Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
- (2021) Sue A. Brown et al. DIABETES CARE
- Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial
- (2021) Charlotte K. Boughton et al. NATURE MEDICINE
- Adjunctive Therapies to Optimize Closed-loop Glucose Control
- (2021) Shylaja Srinivasan et al. Journal of diabetes science and technology
- 6. Glycemic Targets: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin
- (2021) Grazia Aleppo et al. DIABETES CARE
- 7. Diabetes Technology: Standards of Medical Care in Diabetes—2022
- (2021) DIABETES CARE
- Clinical Implementation of the Omnipod 5 Automated Insulin Delivery System: Key Considerations for Training and Onboarding People With Diabetes
- (2021) Cari Berget et al. Clinical Diabetes
- CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM – 2020 EXECUTIVE SUMMARY
- (2020) Alan J. Garber et al. Endocrine Practice
- Add‐on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The DAPADream study
- (2020) Torben Biester et al. DIABETES OBESITY & METABOLISM
- First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 Diabetes
- (2020) Gregory P. Forlenza et al. Diabetes Technology & Therapeutics
- Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial
- (2019) Charlotte K Boughton et al. Lancet Diabetes & Endocrinology
- Fully closed-loop insulin delivery Improves glucose control of inpatients with type 2 diabetes receiving hemodialysis
- (2019) Lia Bally et al. KIDNEY INTERNATIONAL
- Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
- (2019) Sue A. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolution of Diabetes Technology
- (2019) Klemen Dovc et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Closed-Loop Insulin Delivery for Glycemic Control in Noncritical Care
- (2018) Lia Bally et al. NEW ENGLAND JOURNAL OF MEDICINE
- Type 2 diabetes in adolescents and young adults
- (2018) Nadia Lascar et al. Lancet Diabetes & Endocrinology
- Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETES CARE
- Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial
- (2018) Martin Tauschmann et al. LANCET
- Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials
- (2017) Sophia Zoungas et al. Lancet Diabetes & Endocrinology
- Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial
- (2017) Hood Thabit et al. Lancet Diabetes & Endocrinology
- Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes
- (2016) Richard M. Bergenstal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Racial/ethnic disparities in prevalence and care of patients with type 2 diabetes mellitus
- (2015) Keith C. Ferdinand et al. CURRENT MEDICAL RESEARCH AND OPINION
- Development of a New Measure for Assessing Insulin Delivery Device Satisfaction in Patients with Type 1 and Type 2 Diabetes
- (2015) William H. Polonsky et al. Diabetes Technology & Therapeutics
- Clinical Inertia in People With Type 2 Diabetes: A retrospective cohort study of more than 80,000 people
- (2013) K. Khunti et al. DIABETES CARE
- Feasibility of Closed-Loop Insulin Delivery in Type 2 Diabetes: A Randomized Controlled Study
- (2013) Kavita Kumareswaran et al. DIABETES CARE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search